Cannon Global Investment Management’s Aclaris Therapeutics ACRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-37,400	Closed	-$57.2K	–	68
2025 Q1	$57.2K	Buy	+37,400	New	+$57.2K	0.1%	73